Elgin woman's book chronicles taking care of her mother with Alzheimer's, who believed their roles were reversed and that the author was her mom.
Pam Singleton never gave birth to a child. But that ultimately didn't stop her from being a mother, even in a most unlikely manner.
by signing up you agree to our terms of service "I would cry all the way home," she said."I'd get there and think, 'I'm not going to be able to maintain this.' It's just so draining."
From that point, Singleton's approach to caregiving -- and the satisfaction both got from it -- changed.
Singleton said she saw the role reversal as beneficial to both of them. Her mom was less anxious, and Singleton was more able to focus on the positives.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Iowa Alzheimer's care facility is fined $10,000 after pronouncing a living woman deadThe woman was unresponsive, and nurses were unable to detect her breathing. A state agency report found the facility 'failed to ensure residents received dignified treatment and care at end of life.'
Read more »
Iowa Alzheimer's care facility is fined $10,000 after pronouncing a living woman deadThe woman was unresponsive, and nurses were unable to detect her breathing. A state agency report found the facility 'failed to ensure residents received dignified treatment and care at end of life.'
Read more »
Why a new Alzheimer’s drug is having a slow U.S. debutThe first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away.
Read more »
Why a new Alzheimer's drug is having a slow US debutThe first drug to show that it slows Alzheimer's is on sale, but treatment for most patients is still several months away. Here's why.
Read more »
Why a new Alzheimer's drug is having a slow US debutThe first drug to show that it slows Alzheimer's is on sale, but treatment for most patients is still several months away. Here's why.
Read more »
Why a new Alzheimer's drug is having a slow US debutThe first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away. Two big factors behind the slow debut, experts say, are scant insurance coverage and a long setup time needed by many health systems.
Read more »